Curium Pharma Tech Stack

Nuclear medicine diagnostics and therapeutics manufacturer focused on oncology

Pharmaceutical Manufacturing Boston, Massachusetts 1,001–5,000 employees Founded 2017 Privately Held

Curium manufactures radiopharmaceuticals for diagnostic imaging and cancer treatment, with a explicit pivot toward oncology and prostate cancer PSMA therapy. The hiring pattern is heavily sales-driven (34 of 88 open roles) with significant manufacturing and operations capacity, reflecting a company scaling commercial reach ahead of new product launches. Tech stack is operational-grade (Infor XA, LIMS, ServiceNow) rather than data-forward, and the pain-point cluster around managed care access and formulary placement signals a go-to-market friction point that sales velocity is meant to address.

Tech Stack 21 technologies

Core StackPower BI Airtable Power Platform Make Active Directory ServiceNow Windows Server Microsoft Office Excel Qubes Outlook Teams Infor XA Komodo LIMS Bubble HPLC GCP Windows PowerShell

What Curium Pharma Is Building

◆Challenges

Managed care access
New product launches
Streamlining compliance tasks
Maintaining operational compliance
Compliance and administrative tasks
Ensuring gmp compliance
Meeting sales targets
Expanding formulary placement
Optimizing patient care pathway
Optimiser le portefeuille fournisseurs

▲Active Projects

New product launches
Account specific business plans
Adding products to hospital formularies
Launch of tep psma imaging agent for prostate cancer
Institution-specific strategies
Managed care access opportunities
Projets capex
Technical support and training
Psma pet engagement program
Regional rollout of tep psma

Hiring Activity

Accelerating90 roles · 45 in 30d

Department

Sales

Manufacturing

Ops

Engineering

Finance

Healthcare

Data

Marketing

Seniority

Mid

Senior

Junior

Manager

Director

Intern

Notable leadership hires: Director Técnico, Medical Director

Company intelligence

Find more companies like Curium Pharma by tech stack, pain points and active projects

Get started free

About Curium Pharma

Curium is a global radiopharmaceutical manufacturer headquartered in Boston with 1,001–5,000 employees across manufacturing, sales, and support functions in 11 countries. The company develops, manufactures, and distributes nuclear medicine products for cancer diagnostics and treatment, with current clinical focus on neuroendocrine tumors and PSMA imaging for prostate cancer. Active projects include regional rollout of a PSMA PET imaging agent, institution-specific market penetration strategies, and formulary placement expansion. Manufacturing and compliance operations span cGMP production, contract manufacturing services, and technical training delivery to hospital partners.

HeadquartersBoston, Massachusetts

Company Size1,001–5,000 employees

Founded2017

Hiring MarketsItaly, United States, France, Turkey, Czechia, Spain, Belgium, Ireland

Frequently Asked Questions

What is Curium Pharma's main product focus?

Curium develops and manufactures radiopharmaceutical diagnostics and therapeutics, with current oncology focus on neuroendocrine tumors and PSMA imaging for prostate cancer treatment and diagnosis.

Where is Curium Pharma headquartered and how large is it?

Curium is headquartered in Boston, Massachusetts, and employs 1,001–5,000 people. The company hires across 11 countries including the US, Italy, France, UK, and Netherlands.